Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Quart Barry D
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-10-03
Purchase
2019-10-04
7:58 pm
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
4,571 $17.5 $79,993 95,458
(Direct)
View
2018-06-21
Sale
2018-06-22
9:35 pm
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
50,000 $39.05 $1,952,500 321,207
(Direct)
View
2018-03-19
Sale
2018-03-19
7:22 pm
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
100,000 $29.75 $2,975,000 798,269
(Direct)
View
2018-03-14
Sale
2018-03-16
9:00 pm
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
100,000 $24.75 $2,475,000 898,269
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-07-13
Other
2022-07-15
4:57 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
1,504 $3.842 328,604
(Direct)
View
2022-07-13
Tax Withholding
2022-07-15
4:57 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
5,219 $3.01 328,604
(Direct)
View
2022-07-13
Exercise
2022-07-15
4:57 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
19,768 $0 328,604
(Direct)
View
2022-06-29
Option Award
2022-06-30
4:22 pm
N/A
2032-06-28
Kiniksa Pharmaceuticals Ltd. KNSA Quart Barry D
Director
35,000 $0 35,000
(Direct)
View
2022-04-13
Tax Withholding
2022-04-15
5:05 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
5,219 $6.07 330,815
(Direct)
View
2022-04-13
Exercise
2022-04-15
5:05 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
19,768 $0 330,815
(Direct)
View
2022-01-13
Tax Withholding
2022-01-14
5:08 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
5,219 $8.3 336,034
(Direct)
View
2022-01-13
Exercise
2022-01-14
5:08 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
19,768 $0 336,034
(Direct)
View
2021-10-13
Tax Withholding
2021-10-15
4:25 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
963 $10.55 732,087
(Direct)
View
2021-10-13
Option Award
2021-10-15
4:25 pm
N/A
2031-10-13
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
586,251 $0 732,087
(Direct)
View
2021-10-13
Exercise
2021-10-15
4:25 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
3,646 $0 732,087
(Direct)
View
2021-07-13
Tax Withholding
2021-07-15
4:50 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
963 $13.48 148,328
(Direct)
View
2021-07-13
Other
2021-07-15
4:50 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
1,529 $13.9 148,328
(Direct)
View
2021-07-13
Exercise
2021-07-15
4:50 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
3,645 $0 148,328
(Direct)
View
2021-06-29
Option Award
2021-06-30
4:20 pm
N/A
2031-06-28
Kiniksa Pharmaceuticals Ltd. KNSA Quart Barry D
Director
33,237 $0 33,237
(Direct)
View
2021-01-13
Tax Withholding
2021-01-15
4:29 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
963 $18.16 146,596
(Direct)
View
2021-01-13
Exercise
2021-01-15
4:29 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
3,646 $0 146,596
(Direct)
View
2020-10-13
Option Award
2020-10-15
4:23 pm
N/A
2030-10-13
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
408,333 $0 498,717
(Direct)
View
2020-10-13
Other
2020-10-15
4:23 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
1,158 $12.12 498,717
(Direct)
View
2020-06-30
Option Award
2020-07-02
4:12 pm
N/A
2030-06-29
Kiniksa Pharmaceuticals Ltd. KNSA Quart Barry D
Director
18,760 $0 18,760
(Direct)
View
2019-12-31
Ownership
2020-02-14
4:56 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
6,584 $0 88,068
(Direct)
View
2019-12-19
Option Award
2019-12-23
4:29 pm
N/A
2029-12-19
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
325,000 $0 325,000
(Direct)
View
2019-10-03
Other
2019-10-04
7:58 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
806 $18.43 95,458
(Direct)
View
2019-05-29
Option Award
2019-05-30
6:33 pm
N/A
2029-05-28
Kiniksa Pharmaceuticals Ltd. KNSA Quart Barry D
Director
18,760 $0 18,760
(Direct)
View
2018-12-15
Option Award
2018-12-18
8:09 pm
N/A
2028-12-15
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
300,000 $0 300,000
(Direct)
View
2018-09-14
Exercise
2018-09-14
11:41 am
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
19,675 $7.2 799,876
(Direct)
View
2018-09-14
Exercise
2018-09-14
11:41 am
N/A
2023-05-01
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
19,675 $0 799,876
(Direct)
View
2018-06-21
Other
2018-06-22
9:35 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
1,607 $13.22 321,207
(Direct)
View
2018-06-21
Exercise
2018-06-22
9:35 pm
N/A
2024-12-12
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
50,000 $0 321,207
(Direct)
View
2018-06-21
Exercise
2018-06-22
9:35 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
50,000 $9.05 321,207
(Direct)
View
2018-05-23
Ownership
2018-05-23
8:11 pm
N/A
2025-12-15
Kiniksa Pharmaceuticals Ltd. KNSA Quart Barry D
Director
0 $0 69,536
(Direct)
View
2018-03-19
Exercise
2018-03-19
7:22 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
100,000 $7.2 798,269
(Direct)
View
2018-03-19
Exercise
2018-03-19
7:22 pm
N/A
2023-05-01
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
100,000 $0 798,269
(Direct)
View
2018-03-14
Exercise
2018-03-16
9:00 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
100,000 $7.2 898,269
(Direct)
View
2018-03-14
Exercise
2018-03-16
9:00 pm
N/A
2023-05-01
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
100,000 $0 898,269
(Direct)
View
2017-12-18
Option Award
2017-12-20
4:15 pm
N/A
2027-12-18
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
310,000 $0 379,677
(Direct)
View
2017-12-18
Other
2017-12-20
4:15 pm
N/A
N/A
HERON THERAPEUTICS Inc HRTX Quart Barry D
CEO
1,684 $12.62 379,677
(Direct)
View